Quotes 5-day view Delayed Nyse
08/02/2022
08/03/2022
08/04/2022
08/05/2022
08/08/2022
Date
178.83(c)
180.16(c)
174.31(c)
174.61(c)
174.01 Last
1 180 167
1 659 911
2 391 121
1 523 552
1 231 699 Volume
-0.51% +0.74% -3.25% +0.17% -0.34% Change
Estimated financial data (e) (USD)
Sales 2022
8 264 M - -
Net income 2022
2 193 M - -
Net Debt 2022
2 577 M - -
P/E ratio 2022
37,1x
Yield 2022
0,72%
Sales 2023
8 934 M - -
Net income 2023
2 401 M - -
Net Debt 2023
1 001 M - -
P/E ratio 2023
33,5x
Yield 2023
0,82%
Capitalization
81 461 M 81 461 M -
EV / Sales 2022
10,2x
EV / Sales 2023
9,23x
Nbr of Employees
12 100
Free-Float
92,4%
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (54.7%): cats and dogs (94.1% of net sales) and horses (5.9%);
- livestock (44.1%): cattle (53% of sales), swine (21.1%), poultry (18.3%), fish (5%) and other (1.2%);
- other (1.2%).
Net sales break down by family of products into vaccines (22.1%), anti-infectives...
News in other languages on ZOETIS
Analyst Recommendations on ZOETIS
Drug, feed ingredient shortages hit U.S. livestock producers
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ZOETIS
Short Term Mid-Term Long Term Trends Neutral Neutral Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
15
Last Close Price
174,01 $
Average target price
225,64 $
Spread / Average Target
29,7%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capi. (M$)
ZOETIS -28.45% 81 742
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
